Koechling, W., Hjortkjaer, R., & Tankó, L. B. (2010). Degarelix, a novel GnRH antagonist, causes minimal histamine release compared with cetrorelix, abarelix and ganirelix in an ex vivo model of human skin samples. British journal of clinical pharmacology, 70(4), 580-587. https://doi.org/10.1111/j.1365-2125.2010.03730.x
Chicago Style (17th ed.) CitationKoechling, Wolfgang, Rolf Hjortkjaer, and László B. Tankó. "Degarelix, a Novel GnRH Antagonist, Causes Minimal Histamine Release Compared with Cetrorelix, Abarelix and Ganirelix in an Ex Vivo Model of Human Skin Samples." British Journal of Clinical Pharmacology 70, no. 4 (2010): 580-587. https://doi.org/10.1111/j.1365-2125.2010.03730.x.
MLA (9th ed.) CitationKoechling, Wolfgang, et al. "Degarelix, a Novel GnRH Antagonist, Causes Minimal Histamine Release Compared with Cetrorelix, Abarelix and Ganirelix in an Ex Vivo Model of Human Skin Samples." British Journal of Clinical Pharmacology, vol. 70, no. 4, 2010, pp. 580-587, https://doi.org/10.1111/j.1365-2125.2010.03730.x.